New pill shows promise against tough prostate cancer

NCT ID NCT05067140

Ongoing Disease control Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests an experimental drug called ARV-766, taken as a pill, in men with prostate cancer that has spread to other parts of the body. The drug is given alone or with another medicine (abiraterone) to see if it is safe and can slow the cancer. About 152 men will take part in this early-phase trial.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

male reproductive organ cancer metastatic prostate carcinoma prostate cancer Urogenital Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER METASTATIC

Contacts and locations

Locations

Clinical Trial Site

Duarte, California, 91010, United States
Clinical Trial Site

Fresno, California, 93720, United States
Clinical Trial Site

La Jolla, California, 92037, United States
Clinical Trial Site

Orange, California, 92868, United States
Clinical Trial Site

Santa Monica, California, 90404, United States
Clinical Trial Site

New Haven, Connecticut, 06510, United States
Clinical Trial Site

Washington D.C., District of Columbia, 20007, United States
Clinical Trial Site

Lake Mary, Florida, 32746, United States
Clinical Trial Site

Chicago, Illinois, 60611, United States
Clinical Trial Site

New Orleans, Louisiana, 70112, United States
Clinical Trial Site

Baltimore, Maryland, 21204, United States
Clinical Trial Site

Boston, Massachusetts, 02114, United States
Clinical Trial Site

Detroit, Michigan, 48201, United States
Clinical Trial Site

Buffalo, New York, 14203, United States
Clinical Trial Site

New York, New York, 10065, United States
Clinical Trial Site

Philadelphia, Pennsylvania, 19144, United States
Clinical Trial Site

Pittsburgh, Pennsylvania, 15232, United States
Clinical Trial Site

Myrtle Beach, South Carolina, 29572, United States
Clinical Trial Site

Nashville, Tennessee, 37203, United States
Clinical Trial Site

San Antonio, Texas, 78229, United States
Clinical Trial Site

Charlottesville, Virginia, 22908, United States
Clinical Trial Site

Fairfax, Virginia, 22031, United States
Clinical Trial Site

Madison, Wisconsin, 53705, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.